Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...

Vestas Wind Systems faces challenges like geopolitical risks and competition. Find out why its valuation drop may not make it ...

A Twitch streamer has been fined for promoting unlicensed gambling sites by the Danish authorities. Here’s what we know.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Investing.com -- Lundbeck (CSE: HLUNb) on Wednesday raised its full-year revenue and earnings guidance after reporting a 16% increase in first-quarter revenue at constant exchange rates to DKK 6.24 ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Interim Management Statement covering Q3 2024/25 The Board of Directors of Rovsing A/S has today reviewed and approved the ...

Morgan Stanley lowered the firm’s price target on Demant (WILYY) to DKK 310 from DKK 325 and keeps an Overweight rating on the shares. Published ...

Torm shares rose as much as 6% in Copenhagen after Pareto Securities upgraded to buy from hold. Head of research Eirik ...

Nini Pryds, Henning Friis Poulsen, Irini Angelidaki, and Leif Oxenløwe each received a prestigious Villum Investigator grant, ...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...